News

Press Releases

Sep 14, 2004

Mylan Announces Investor Roadshow Regarding the King Acquisition and Update on Nebivolol
Sep 8, 2004

Mylan Lowers Shareholder Rights Plan Threshold From 15% To 10%
Sep 8, 2004

Mylan Responds to Carl Icahn's 13D Filing
Sep 7, 2004

Mylan Completes Next Step in Proposed Acquisition of King Pharmaceuticals with Filing of Form S-4 Registration Statement
Aug 30, 2004

Mylan Withdraws Lawsuit in Order to Consider Additional Authorized Generics Claims
Aug 30, 2004

Mylan Reports Positive Study on Nebivolol Demonstrating Nebivolol Reduces the Risk of All Cause Mortality and Cardiovascular Hospitalization in Elderly Heart Failure Patients as Reported at the ESC
Aug 23, 2004

Mylan Receives FDA Approval for Metoprolol Tartrate and Hydrochlorothiazide Tablets

Mylan Also Announces Tentative Approval for Cetirizine Hydrochloride Tablets and Sertraline Hydrochloride Tablets
Aug 20, 2004

Mylan Comments on Yesterday's Trading Activity
Aug 19, 2004

FTC Grants Early Termination for Stock Purchase By Icahn
Aug 18, 2004

Mylan Seeks Immediate Appeal on Fentanyl Ruling

Show per page

Mylan: Seeing is Believing

You are leaving Mylan.com

By clicking Continue below you are leaving Mylan.com and going to a third-party site.

Continue

Go back